Royalty Pharma plc ( RPRX) - Key Metrics

RPRX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2024Q4 $1.33 $0.46 $1.66 $1.66
2024Q3 $1.26 $1.22 $1.57 $3.41
2024Q2 $1.19 $0.23 $1.47 -$0.19
2024Q1 $1.27 $0.01 $1.49 $1.30
2023Q4 $1.33 $1.11 $1.74 -$0.50

RPRX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2024Q4 45.03% 13.72
2024Q3 17.29% 5.82
2024Q2 93.08% 28.95
2024Q1 1963.27% 701.85
2023Q4 18.07% 6.34

RPRX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2024Q4 6.51% 0.82%
2024Q3 12.06% 0.74%
2024Q2 -0.72% 0.80%
2024Q1 4.35% 0.70%
2023Q4 -1.79% 0.71%

RPRX

List: Challengers

Price: $33.73

52 week price:
24.05
34.20

Dividend Yield: 2.72%

5-year range yield:
1.50%
3.00%

Forward Dividend Yield: 2.63%

Payout Ratio: 56.00%

Payout Ratio Range:
-206.31%
1963.27%

Dividend Per Share: 0.88 USD

Earnings Per Share: 1.91 USD

P/E Ratio: 17.45

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 1.0 million

Ebitda: -16.0 million

Market Capitalization: 14.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 6

DGR3: 21.38%

Links: